Anxiety Disorders, COPD, Depressive Disorder
Conditions
Keywords
Metacognitions, Hospital Anxiety and Depression Scale
Brief summary
The current cohort study of 300 stable COPD patients aims to assess the following topics: * The prevalence of anxiety and depressive disorders in patients with COPD * The screening properties of Hospital Anxiety and Depression Scale in patients with COPD * The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder. * whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome
Interventions
None listed
Sponsors
University of Oslo
LHL Hospital Gardermoen
Priory Hospital Altrincham
University Hospital, Akershus
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participant in in-hospital pulmonary rehabilitation at LHL-hospital Gardermoen * Diagnosis of COPD
Exclusion criteria
* Acute exacerbated phase of COPD
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COPD exacerbation rate | 3 years | The number of moderate or severe exacerbations |
| Mortality rate | 3 years | The number of deaths |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of Health-related Quality of Life With RAND-36 | 3 years | The total score and subscale scores on RAND 36 |
Other
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of anxiety disorder | 1 year | Clinically diagnosed anxiety disorders |
| The prevalence of depressive disorder | 1 year | Clinically diagnosed depressive disorder |
Countries
Norway
Outcome results
None listed